Rekah Pharmaceutical Industry Ltd (REKA) — Capital Reinvestment Ratio
Rekah Pharmaceutical Industry Ltd (REKA) has a Capital Reinvestment Ratio of 0.40x as of December 2025, meaning it reinvests 0% of its operating cash flow (ILA5.27 Million) in capital expenditures (ILA2.10 Million). See REKA net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Rekah Pharmaceutical Industry Ltd Capital Reinvestment Ratio (2002–2025)
This chart tracks Rekah Pharmaceutical Industry Ltd's Capital Reinvestment Ratio across 21 annual periods. Check REKA total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Rekah Pharmaceutical Industry Ltd (2002–2025)
Year-by-year Capital Reinvestment Ratio for Rekah Pharmaceutical Industry Ltd from 2002 to 2025. For live market cap and broader valuation context, see Rekah Pharmaceutical Industry Ltd (REKA) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (ILA) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.54x | ILA12.95 Million | ILA7.03 Million | ▲ +65.5% |
| 2024 | 0.33x | ILA26.54 Million | ILA8.70 Million | ▼ -19.1% |
| 2023 | 0.41x | ILA28.35 Million | ILA11.49 Million | ▲ +111.3% |
| 2022 | 0.19x | ILA39.00 Million | ILA7.48 Million | ▼ -71.0% |
| 2021 | 0.66x | ILA21.17 Million | ILA13.99 Million | ▼ -60.4% |
| 2020 | 1.67x | ILA11.28 Million | ILA18.84 Million | ▲ +24.7% |
| 2019 | 1.34x | ILA33.91 Million | ILA45.40 Million | ▲ +52.5% |
| 2018 | 0.88x | ILA17.28 Million | ILA15.18 Million | ▲ +26.8% |
| 2017 | 0.69x | ILA23.80 Million | ILA16.48 Million | ▲ +17.6% |
| 2016 | 0.59x | ILA22.82 Million | ILA13.44 Million | ▼ -74.0% |
| 2015 | 2.26x | ILA5.81 Million | ILA13.15 Million | ▼ -84.4% |
| 2014 | 14.49x | ILA1.33 Million | ILA19.27 Million | ▲ +3767.8% |
| 2013 | 0.37x | ILA11.71 Million | ILA4.38 Million | ▼ -45.9% |
| 2012 | 0.69x | ILA14.18 Million | ILA9.82 Million | ▼ -40.8% |
| 2010 | 1.17x | ILA6.73 Million | ILA7.87 Million | ▲ +226.1% |
| 2009 | 0.36x | ILA26.03 Million | ILA9.33 Million | ▼ -78.0% |
| 2008 | 1.63x | ILA6.57 Million | ILA10.73 Million | ▲ +285.0% |
| 2007 | 0.42x | ILA12.45 Million | ILA5.28 Million | ▼ -74.4% |
| 2005 | 1.66x | ILA4.27 Million | ILA7.09 Million | ▲ +530.7% |
| 2004 | 0.26x | ILA17.87 Million | ILA4.70 Million | ▲ +20.9% |
| 2002 | 0.22x | ILA11.21 Million | ILA2.44 Million | — |